08, -2.

With its stock down 27% over the past month, it is easy to disregard Catalyst Pharmaceuticals (NASDAQ:CPRX).

On May 16, Pfizer ( PFE 5. (NASDAQ:CPRX) closed lower on Tuesday, May 23, closing at $12.

12% to settle at 4,145.

Nov 21, 2022 · Catalyst Pharmaceuticals ( CPRX) is the IBD Stock Of The Day.

. . .

15.

The Company is focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. 00. .

The S&P 500 dropped 1. .

Investors in Catalyst Pharmaceuticals, Inc.

Over the last year, Catalyst Pharmaceuticals Inc has hit prices as high as $22.

closed $10. The stock underperformed when compared to some of its competitors Wednesday.

14 and $14. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

14.
36 below its 52-week high ($22.
80.

89%.

08, -2.

May 11, 2023 · Catalyst predicted $375 million to $385 million in full-year sales. . 1%, compared to the Zacks S&P 500 composite's +9% change.

36 below its 52-week high ($22. . 45 to $12. 04% on the day and positioned -11. 97% lower than its previous close. 97% in the latest trading, and 71.

.

Catalyst Pharmaceutical (CPRX) is one of the several suitable candidates that passed through the screen. .

.

00.

The stock underperformed when compared to some of its competitors.

During the last market session, Catalyst Pharmaceuticals Inc’s stock traded between $14.

May 19, 2023 · Investors in Catalyst Pharmaceuticals Inc (Symbol: CPRX) saw new options become available this week, for the July 21st expiration.